Columbia University, New York, New York 10032, USA.
J Clin Endocrinol Metab. 2012 Aug;97(8):2782-91. doi: 10.1210/jc.2012-1477. Epub 2012 Jun 14.
We have previously reported that premenopausal women with idiopathic osteoporosis based on fractures (IOP) or idiopathic low bone mineral density (ILBMD) exhibit markedly reduced bone mass, profoundly abnormal trabecular microstructure, and significant deficits in trabecular bone stiffness. Bone remodeling was heterogeneous. Those with low bone turnover had evidence of osteoblast dysfunction and the most marked deficits in microstructure and stiffness.
Because osteoblasts and marrow adipocytes derive from a common mesenchymal precursor and excess marrow fat has been implicated in the pathogenesis of bone fragility in anorexia nervosa, glucocorticoid excess, and thiazolidinedione exposure, we hypothesized that marrow adiposity would be higher in affected women and inversely related to bone mass, microarchitecture, bone formation rate, and osteoblast number.
We analyzed tetracycline-labeled transiliac biopsy specimens in 64 premenopausal women with IOP or ILBMD and 40 controls by three-dimensional micro-computed tomography and two-dimensional quantitative histomorphometry to assess marrow adipocyte number, perimeter, and area.
IOP and ILBMD subjects did not differ with regard to any adipocyte parameter, and thus results were combined. Subjects had substantially higher adipocyte number (by 22%), size (by 24%), and volume (by 26%) than controls (P < 0.0001 for all). Results remained significant after adjusting for age, body mass index, and bone volume. Controls demonstrated expected direct associations between marrow adiposity and age and inverse relationships between marrow adiposity and bone formation, volume, and microstructure measures. No such relationships were observed in the subjects.
Higher marrow adiposity and the absence of expected relationships between marrow adiposity and bone microstructure and remodeling in women with IOP or ILBMD suggest that the relationships between fat and bone are abnormal; excess marrow fat may not arise from a switch from the osteoblast to the adipocyte lineage in this disorder. Whether excess marrow fat contributes to the pathogenesis of this disorder remains unclear.
我们之前报道过,基于骨折(IOP)或特发性低骨密度(ILBMD)的绝经前女性表现出明显的骨量减少、明显异常的小梁微观结构以及小梁骨刚度显著降低。骨重塑是异质的。那些骨转换率低的患者有破骨细胞功能障碍的证据,并且在微观结构和刚度方面存在最显著的缺陷。
由于成骨细胞和骨髓脂肪细胞来源于共同的间充质前体,并且过量的骨髓脂肪已被认为与神经性厌食症、皮质类固醇过量和噻唑烷二酮暴露导致的骨脆弱性的发病机制有关,我们假设受影响的女性骨髓脂肪含量会更高,并且与骨量、微结构、骨形成率和成骨细胞数量呈负相关。
我们通过三维微计算机断层扫描和二维定量组织形态计量学分析了 64 名患有 IOP 或 ILBMD 的绝经前女性和 40 名对照者的四环素标记的髂嵴活检标本,以评估骨髓脂肪细胞数量、周长和面积。
IOP 和 ILBMD 受试者在任何脂肪细胞参数方面均无差异,因此将结果合并。与对照组相比,受试者的脂肪细胞数量(增加 22%)、大小(增加 24%)和体积(增加 26%)都明显更高(所有 P<0.0001)。在调整年龄、体重指数和骨量后,结果仍然显著。对照组显示出骨髓脂肪与年龄之间的直接关联,以及骨髓脂肪与骨形成、体积和微观结构测量值之间的负相关。在受试者中没有观察到这种关系。
在患有 IOP 或 ILBMD 的女性中,较高的骨髓脂肪量和骨髓脂肪量与骨微观结构和重塑之间缺乏预期的关系表明,脂肪与骨之间的关系异常;在这种疾病中,过量的骨髓脂肪可能不是源于破骨细胞向脂肪细胞谱系的转变。过量的骨髓脂肪是否导致这种疾病的发病机制尚不清楚。